Matches in Nanopublications for { ?s ?p "[LAMC2 is a novel biomarker of bladder cancer metastasis that reflects the propensity of cells to metastasize via either lymphatic or hematogenous routes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP102497.RAemNo-6ZAJEeuxTkM_YPgude2BC2RDpJ3E5bkakwCQaY130_assertion description "[LAMC2 is a novel biomarker of bladder cancer metastasis that reflects the propensity of cells to metastasize via either lymphatic or hematogenous routes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP102497.RAemNo-6ZAJEeuxTkM_YPgude2BC2RDpJ3E5bkakwCQaY130_provenance.
- NP129561.RASeAwGv93NGlgZFQ6Q2w5p78nzJKBIBDtFNf6epeqo68130_assertion description "[LAMC2 is a novel biomarker of bladder cancer metastasis that reflects the propensity of cells to metastasize via either lymphatic or hematogenous routes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP129561.RASeAwGv93NGlgZFQ6Q2w5p78nzJKBIBDtFNf6epeqo68130_provenance.
- NP192737.RAZDN7Dm6dsZnIJU9jenKl4Fslm5W0wJCtLbJ13hXgT70130_assertion description "[LAMC2 is a novel biomarker of bladder cancer metastasis that reflects the propensity of cells to metastasize via either lymphatic or hematogenous routes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP192737.RAZDN7Dm6dsZnIJU9jenKl4Fslm5W0wJCtLbJ13hXgT70130_provenance.
- NP165720.RA91GenpR76UvfN9a_vgq-ZywC7p3W6_znEan16xLAPQY130_assertion description "[LAMC2 is a novel biomarker of bladder cancer metastasis that reflects the propensity of cells to metastasize via either lymphatic or hematogenous routes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165720.RA91GenpR76UvfN9a_vgq-ZywC7p3W6_znEan16xLAPQY130_provenance.
- assertion description "[LAMC2 is a novel biomarker of bladder cancer metastasis that reflects the propensity of cells to metastasize via either lymphatic or hematogenous routes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[LAMC2 is a novel biomarker of bladder cancer metastasis that reflects the propensity of cells to metastasize via either lymphatic or hematogenous routes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP245023.RAQ_9aFRJzIFPSHflATHKLrjp1NvWFTOjLkIPmhVyo1JE130_assertion description "[LAMC2 is a novel biomarker of bladder cancer metastasis that reflects the propensity of cells to metastasize via either lymphatic or hematogenous routes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245023.RAQ_9aFRJzIFPSHflATHKLrjp1NvWFTOjLkIPmhVyo1JE130_provenance.
- NP245024.RAs2fDpw0S12J-74u71Y583lFTQVkpGnrxUwQJvRglNrs130_assertion description "[LAMC2 is a novel biomarker of bladder cancer metastasis that reflects the propensity of cells to metastasize via either lymphatic or hematogenous routes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245024.RAs2fDpw0S12J-74u71Y583lFTQVkpGnrxUwQJvRglNrs130_provenance.